IDEAS home Printed from https://ideas.repec.org/p/hal/journl/halshs-00680996.html
   My bibliography  Save this paper

A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)

Author

Listed:
  • Catherine Sebban

    (Department of Medical Oncology - Centre Léon Bérard [Lyon])

  • Anne Lefranc

    (Centre Léon Bérard [Lyon])

  • Lionel Perrier

    (Centre Léon Bérard [Lyon], GATE Lyon Saint-Étienne - Groupe d'Analyse et de Théorie Economique Lyon - Saint-Etienne - ENS de Lyon - École normale supérieure de Lyon - UL2 - Université Lumière - Lyon 2 - UCBL - Université Claude Bernard Lyon 1 - Université de Lyon - UJM - Université Jean Monnet - Saint-Étienne - CNRS - Centre National de la Recherche Scientifique)

  • Philippe Moreau

    (Hématologie et oncologie pédiatrique)

  • Daniel Espinouse

    (Hématologie clinique - CHU Lyon)

  • A. Schmidt

    (Centre Léon Bérard [Lyon])

  • L. Kammoun

    (Centre Léon Bérard [Lyon])

  • Hervé Ghesquières

    (FNCLCC - Département Hématologie - Centre Léon Bérard [Lyon])

  • C. Ferlay

    (Centre Léon Bérard [Lyon])

  • Jacques-Olivier Bay

    (Laboratoire OncoGènAuvergne [Centre Jean Perrin - Clermont-Ferrand] - UNICANCER/CJP - Centre Jean Perrin [Clermont-Ferrand] - UNICANCER)

  • Séverine Lissandre

    (Service d'hématologie [Tours] - CHRU Tours - Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau)

  • David Pérol

    (Department of Biostatistics - Centre Léon Bérard [Lyon])

  • M. Michallet

    (Centre Léon Bérard [Lyon])

  • Philippe Quittet

    (Service d'hématologie et oncologie médicale - Hôpital Lapeyronie [CHU Montpellier] - CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier] - UM1 - Université Montpellier 1 - CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier] - UM - Université de Montpellier)

Abstract

No abstract is available for this item.

Suggested Citation

  • Catherine Sebban & Anne Lefranc & Lionel Perrier & Philippe Moreau & Daniel Espinouse & A. Schmidt & L. Kammoun & Hervé Ghesquières & C. Ferlay & Jacques-Olivier Bay & Séverine Lissandre & David Pérol, 2012. "A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)," Post-Print halshs-00680996, HAL.
    • Handle: RePEc:hal:journl:halshs-00680996
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Lionel Perrier & Anne Lefranc & David Pérol & Philippe Quittet & Aline Schmidt-Tanguy & Carole Siani & Christian Peretti & Bertrand Favier & Pierre Biron & Philippe Moreau & Jacques Bay & Séverine Lis, 2013. "Cost Effectiveness of Pegfilgrastim Versus Filgrastim After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Lymphoma and Myeloma," Applied Health Economics and Health Policy, Springer, vol. 11(2), pages 129-138, April.
    2. Simone Cesaro & Francesca Nesi & Gloria Tridello & Massimo Abate & Irene Sara Panizzolo & Rita Balter & Elisabetta Calore, 2013. "A Randomized, Non-Inferiority Study Comparing Efficacy and Safety of a Single Dose of Pegfilgrastim versus Daily Filgrastim in Pediatric Patients after Autologous Peripheral Blood Stem Cell Transplant," PLOS ONE, Public Library of Science, vol. 8(1), pages 1-8, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:halshs-00680996. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.